RxDoctor Payments Data

Jennifer Gerres, DPM

Podiatrist · Silver Spring, MDNPI 1669791133

Payments from drug & device makers

What this record shows

This record is dominated by education: $2,762 of the $3,070 with a category attached, or 90.0%. Supreme Orthopedic Systems, LLC accounts for 91.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $1,577 and has fallen 98.8% since, to $19 in 2025.

$3,070in general payments, 2019–2025

Across 13 payments — averaging $236.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supreme Orthopedic Systems, LLC$3K
  • Organogenesis Inc.$124
  • Zyla Life Sciences, Inc.$29
  • Kerecis Limited$23
  • Amgen$22
  • Pacira Pharmaceuticals Incorporated$21
  • plus $52 from 3 others

What the payments were for

  • Food & beverage$30810%
  • Education$2,76290%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,070 in reported general payments places this provider in the 80th percentile of 183 podiatrist providers in Maryland.

See all podiatrist providers in Maryland

Medicare billing

Part B allowed, 2024
$65,611
Medicare patients
287
Services billed
1,050

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole28$717
Ammonium Lactate29$710
Meloxicam12$31

Paid to pharmacies, not to this prescriber.

Other podiatrist in Silver Spring

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →